| abstract |
PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF 4-PREGENEN-1 1 P-1 7-21 -TRIOL-3,20-DIONE DERIVATIVES The present invention relates to pharmaceutical compositions comprising 4-pregenen 11-17-21 -triol-3,20-dione derivatives, and their use as pharmaceuticals as modulators of the glucocorticoid receptors (GR) and/or the mineralocorticoid receptors (MR). The invention relates specifically to the use of these compounds and their pharmaceutical compositions to treat ocular conditions associated with the glucocorticoid receptors (GR) and/or the mineralocorticoid receptors (MR). |